Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

Market Cap	16.74B
Revenue (ttm)	2.41B
Net Income (ttm)	646.21M
Shares Out	245.35M
EPS (ttm)	2.63
PE Ratio	25.98
Forward PE	n/a
Dividend	1.07 (1.57%)
Ex-Dividend Date	Sep 24, 2025

Volume	10,238,978
Average Volume	12,775,764
Open	74.83
Previous Close	71.15
Day's Range	68.18 - 74.83
52-Week Range	46.45 - 85.65
Beta	0.38
RSI	35.10
Earnings Date	Oct 29, 2025

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory/anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, and dry eye medicines. It also engages in the technol...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1977
• Employees: 2,426
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300573

Financial Performance

In 2024, SHE:300573's revenue was 1.94 billion, an increase of 32.42% compared to the previous year's 1.47 billion. Earnings were 338.06 million, an increase of 40.84%.